Gary Shandling estate gift to establish four separate research funds and a learning studio at UCLA, the university announced on Monday.
UCLA received a sizeable gift from the estate of Garry Shandling this week. Shandling’s 15.2 million dollar philanthropic legacy to the school will benefit medical research in four specific divisisions as well as general medical research at UCLA’s David Geffen School of Medicine: the division of endocrinology, diabetes and hypertension; the division of infectious diseases; and the UCLA Agi Hirshberg Center for Pancreatic Diseases.
“Innovative medical discoveries and breakthrough therapies developed at UCLA have greatly enhanced — and saved — countless lives,” said UCLA Chancellor Gene Block. “Garry Shandling’s bequest is a testament to his belief in what is possible at UCLA, and we are fortunate to have merited his support.”
The endowment establishes the Garry Shandling Endocrine Surgery Research Fund, the Garry Shandling Infectious Diseases Innovation Fund, the Garry Shandling Pancreatic Diseases Fund and the the Garry Shandling Medical Research Fund, which will operate under the direction of the medical school’s dean. In his honor, UCLA also has named the Garry Shandling Learning Studio, a 6,400-square-foot multipurpose space located in Geffen Hall, the school’s medical education building.
Shandling received treatment at the UCLA medical center for a rare endocrine condition called hyperparathyroidism.
Shandling died in 2016.